CD44 and cancer: ARID1B OE significantly increased the number of spheroids (Figure S7, Supporting Information) and elevated the portion of CD44+/CD24‐ and ALDH‐positive cancer stem cell populations (Figure S7, Supporting Information), suggesting that ARID1B plays a critical role in promoting cell survival and the maintenance of cancer stem cells.